What is the brand name of anakinra?
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still’s disease. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein.
What is the prototype interleukin-1 antagonist?
IL-1 is the prototype of the pro-inflammatory cytokines in that it induces the expression of a variety of genes and the synthesis of several proteins that, in turn, induce acute and chronic inflammatory changes.
Is IL-1 an antagonist?
Abstract. The interleukin-1 receptor antagonist (IL-1Ra) is a member of the IL-1 family that binds to IL-1 receptors but does not induce any intracellular response.
What is an interleukin inhibitor?
Interleukin inhibitors are immunosuppressive agents that inhibit the action of interleukins. Interleukins are a group of cytokines (secreted proteins in response to infection) synthesized by white blood cells (lymphocytes, monocytes, and macrophages). They play a key role in the regulation of the immune system.
Which drugs are IL-6 inhibitors?
Four pharmacologic inhibitors (sometimes termed blockers) of IL-6 are commercially available for clinical use: tocilizumab, sarilumab, and satralizumab, which are all monoclonal antibodies directed against the IL-6 receptor (IL-6R), and siltuximab, a monoclonal antibody specific for IL-6.
What drug class is Kineret?
It is also used to treat Cryopyrin-Associated Periodic Syndromes. Anakinra is known as Kineret® and is an IL-1 inhibitor. It is part of a class of drugs called biologics.
What is anakinra used for?
Anakinra is used alone or in combination with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who were not helped by other disease-modifying antirheumatic drugs (DMARDs).
What type of drug is anakinra?
Anakinra is in a class of medications called interleukin antagonists. It works by blocking the activity of interleukin, a substance in the body that causes inflammation.
What are interleukin inhibitors for?
Interleukin (IL) inhibitors may ameliorate severe damage to lung tissue caused by cytokine release in patients with serious COVID-19 infections. Several studies have indicated a “cytokine storm” with release of IL-6, IL-1, IL-12, and IL-18, along with tumor necrosis factor alpha (TNFα) and other inflammatory mediators.
What are IL-6 antagonists?
There are 2 classes of Food and Drug Administration (FDA)-approved IL-6 inhibitors: anti-IL-6 receptor monoclonal antibodies (mAbs) (e.g., sarilumab, tocilizumab) and anti-IL-6 mAbs (i.e., siltuximab). These drugs have been evaluated in patients with COVID-19 who have systemic inflammation.
What is interleukin 6 IL-6 receptor antagonist?
Interleukin (IL)-6 is a pleiotropic, proinflammatory cytokine produced by a variety of cell types, including lymphocytes, monocytes, and fibroblasts. Infection by SARS-CoV induces a dose-dependent production of IL-6 from bronchial epithelial cells.
Is Rituxan an IL-6 inhibitor?
Rituximab induces Interleukin-6 production by human B cells – PMC. The . gov means it’s official.
What type of medicine is anakinra?
What is a recombinant IL-1 receptor antagonist?
A recombinant, slightly modified version of interleukin 1 receptor antagonist called anakinra is used in the treatment of rheumatoid arthritis, an autoimmune disease in which IL-1 plays a key role. Anakinra differs from native human IL-1Ra in that it has the addition of a single methionine residue at its amino terminus.
How does alcohol affect IL-1R1 signaling?
The activity of IL-1 signaling is tightly regulated by IL-1Ra, a natural endogenous antagonist of the proinflammatory IL-1β. IL-1Ra competes with both IL-1α and IL-1β at the receptor level to block IL-1R1 signaling ( 16 ). We observed that alcohol feeding increased endogenous IL-1Ra protein levels in both liver (Figure (Figure6A) (Figure6B)
What is the mechanism of action of IL-1ra?
IL-1ra competitively blocks IL-1 binding to the signaling IL-1R1. A second mechanism of regulation is IL-1R2 or decoy receptor, which can bind both IL-1 and IL-1 accessory protein and can prevent their interaction with an active receptor (i.e., IL-1R1).
Is IL-1Ra a competitive or competitive inhibitor?
IL-1ra is a competitive inhibitor and binds to IL-1R1 with similar affinity as IL-1α and IL-1β, but it has no agonist activity (see Figure 128-2 ).